Showing results (251-260 of 894) with videos related to
Sort By:
Pageof 90
Drugs in R&D|August 30, 2008
No relationship between plasma desacyl-ghrelin levels and rabeprazole-related delay in gastric emptying : controlled study in healthy volunteersTakatsugu Yamamoto, Masaki Sanaka, Hajime Anjiki, et al.Drugs in R&D|September 25, 2021
Dissociated Responses in Patients with Metastatic Solid Tumors Treated with ImmunotherapyPauline Vaflard, Xavier Paoletti, Vincent Servois, et al.Drugs in R&D|October 12, 2019
Are Standard Doses of Renally-Excreted Antiretrovirals in Older Patients Appropriate: A PBPK Study Comparing Exposures in the Elderly Population With Those in Renal ImpairmentM De Sousa Mendes, Manoranjenni ChettyDrugs in R&D|May 16, 2019
Towards a Generic Tool for Prediction of Meropenem Systemic and Infection-Site Exposure: A Physiologically Based Pharmacokinetic Model for Adult Patients with PneumoniaPauline Thémans, Pierre Marquet, Joseph J Winkin, et al.Drugs in R&D|May 18, 2019
Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USAStephanie V Phan, Sharmon Osae, John C Morgan, et al.Drugs in R&D|February 17, 2022
Exebacase: A Novel Approach to the Treatment of Staphylococcal InfectionsMatthew W McCarthyDrugs in R&D|January 31, 2022
Pharmacokinetics of Diazepam and Its Metabolites in Urine of Chinese ParticipantsLe-le Wang, Xin-Xin Ren, Yi He, et al.Drugs in R&D|December 22, 2010
Clopidogrel resistance is associated with long-term thrombotic events in patients implanted with drug-eluting stentsLin Wang, Xiaobei Wang, Fenghua ChenDrugs in R&D|December 22, 2010
Safety, tolerability, and pharmacokinetics of etamicastat, a novel dopamine-β-hydroxylase inhibitor, in a rising multiple-dose study in young healthy subjectsTeresa Nunes, José F Rocha, Manuel Vaz-da-Silva, et al.Drugs in R&D|December 22, 2010
Niacin extended release (ER)/simvastatin (Simcor®): a guide to its use in lipid regulationKatherine A Lyseng-WilliamsonPageof 90